Search Count: 99
 |
N-Terminal Bromodomain Of Human Brd4 With (1R,1'R)-7,7'-(Ethane-1,2-Diylbis(Oxy))Bis(1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2023-11-08 Classification: TRANSCRIPTION Ligands: EDO, ZTT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-11-08
Ligands: EDO, ZTT
 |
N-Terminal Bromodomain Of Human Brd4 With (1R,1'R)-7,7'-(Pentane-1,5-Diylbis(Oxy))Bis(1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.38 Å Release Date: 2023-10-04 Classification: TRANSCRIPTION Ligands: ZTY, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-10-04
Ligands: ZTY, EDO
 |
N-Terminal Bromodomain Of Human Brd4 With I-Bet567
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2022-12-14 Classification: TRANSCRIPTION Ligands: AKQ, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-12-14
Ligands: AKQ, EDO
 |
N-Terminal Bromodomain Of Human Brd4 With I-Bet282
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2021-10-13 Classification: TRANSCRIPTION Ligands: EDO, UYK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-13
Ligands: EDO, UYK
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxo-1-(Tetrahydro-2H-Pyran-4-Yl)Ethyl)-6-Oxo-N-(2-Phenyl-2-(Pyridin-2-Yl)Ethyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2021-10-13 Classification: NUCLEAR PROTEIN Ligands: 80Z, EDO, PE4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-13
Ligands: 80Z, EDO, PE4
 |
Nanobody C5 Bound To Spike
Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Method: ELECTRON MICROSCOPY Resolution:3.00 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG |
Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Method: ELECTRON MICROSCOPY
Release Date: 2021-08-11
Ligands: NAG
 |
Nanobody C5 Bound To Rbd
Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG, ACT |
Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: NAG, ACT
 |
Nanobody H3 And C1 Bound To Rbd
Organism: Lama glama, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG, CIT, CL |
Organism: Lama glama, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: NAG, CIT, CL
 |
Nanobody H3 And C1 Bound To Rbd With Kent Mutation
Organism: Lama glama, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG, CIT, CL |
Organism: Lama glama, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: NAG, CIT, CL
 |
Nanobody C5 Bound To Kent Variant Rbd (N501Y)
Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: NAG, GOL
 |
Nanobody F2 Bound To Rbd
Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama
Method: X-RAY DIFFRACTION Resolution:2.34 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG |
Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama
Method: X-RAY DIFFRACTION
Release Date: 2021-08-11
Ligands: NAG
 |
C-Terminal Bromodomain Of Human Brd2 With N-Methyl-4-Propionyl-1H-Pyrrole-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, V9B |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: EDO, PE4, V9B
 |
C-Terminal Bromodomain Of Human Brd2 With N5-Hydroxycyclohexyl-N3-Methyl-1-Phenylethyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9H, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: V9H, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With N4-Hydroxycyclohexyl-N2-Methyl-5-Phenylethyl-Furan-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9K, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: V9K, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With N5-((1R,5S,6R)-3-Oxabicyclo[3.1.0]Hexan-6-Yl)-3-(1H-Indol-4-Yl)-N7-Methyl-2,3-Dihydrobenzofuran-5,7-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, V9Q |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: EDO, V9Q
 |
C-Terminal Bromodomain Of Human Brd2 With Rac-N5-((1R,5S)-3-Oxabicyclo[3.1.0]Hexan-6-Yl)-N7,3-Dimethyl-3-Phenyl-2,3-Dihydrobenzofuran-5,7-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9N, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: V9N, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With 1-Benzyl-N5-Cyclopropyl-N3-Methyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, VE5, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-28
Ligands: EDO, VE5, PEG
 |
C-Terminal Bromodomain Of Human Brd2 With 6-Benzyl-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: UL5, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: UL5, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With (R)-N5-Cyclopropyl-N3-Methyl-2-Oxo-1-(1-Phenylethyl)-1,2-Dihydropyridine-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.28 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, ULH
 |
C-Terminal Bromodomain Of Human Brd2 With Oxabicyclo(Hexan-6-Yl)-N2-Methyl-6-((S)-1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, ULN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, PE4, ULN